Education
PhD, Université Claude Bernard Lyon 1/INSERM U1111, France, 2016
Current position
Post-doctoral fellow, Cell and Developmental Biology, University of Michigan/Medical School, USA
Publications
-
Maroui, M. A., Calle, A., Cohen, C., Streichenberger, N., Texier, P., Takissian, J., Rousseau, A., Poccardi, N., Welsch, J., Corpet, A., Schaeffer, L., Labetoulle, M. and Lomonte, P. (2016). Latency Entry of Herpes Simplex Virus 1 Is Determined by the Interaction of Its Genome with the Nuclear Environment. PLoS Pathog 12(9): e1005834.
-
Figueira, T. N., Palermo, L. M., Veiga, A. S., Huey, D., Alabi, C. A., Santos, N. C., Welsch, J. C., Mathieu, C., Horvat, B., Niewiesk, S., Moscona, A., Castanho, M. A. R. B. and Porotto, M. (2016). In vivo efficacy of measles virus fusion protein-derived peptides is modulated by properties of self-assembly and membrane residence. J Virol 01554-16.
-
Bloyet, L. M., Welsch, J., Enchery, F., Mathieu, C., de Breyne, S., Horvat, B., Grigorov, B. and Gerlier, D. (2016). HSP90 Chaperoning in Addition to Phosphoprotein Required for Folding but Not for Supporting Enzymatic Activities of Measles and Nipah Virus L Polymerases. J Virol 90(15): 6642-6656.
-
Mathieu, C., Huey, D., Jurgens, E., Welsch, J. C., DeVito, I., Talekar, A., Horvat, B., Niewiesk, S., Moscona, A. and Porotto, M. (2015). Prevention of measles virus infection by intranasal delivery of fusion inhibitor peptides. J Virol 89(2): 1143-1155.
-
Reynaud, J. M., Jégou, J. F., Welsch, J. C. and Horvat, B. (2014). Human herpesvirus 6A infection in CD46 transgenic mice: viral persistence in the brain and increased production of proinflammatory chemokines via Toll-like receptor 9. J Virol 88: 5421–36.
-
Welsch, J. C., Talekar, A., Mathieu, C., Pessi, A., Moscona, A., Horvat, B. and Porotto, M. (2013). Fatal measles virus infection prevented by brain-penetrant fusion inhibitors. J Virol 87(24): 13785-13794.